Ketalux - Ketamine Therapy EducationKetalux - Mental Wellness Authority
Neuroscience

Glutamate: The Brain's Primary Excitatory Signal

The most abundant excitatory neurotransmitter in the brain — and a central player in modern theories of mood and plasticity.

Written by: Ira ZootMedical review status: Pending clinical reviewLast updated: June 6, 2026Evidence: Educational synthesis
Quick answer
Key takeaways
  • Glutamate is the brain's dominant excitatory signal.
  • Glutamate dysfunction is now central to depression theory.
  • Ketamine's downstream glutamate effects may drive its rapid action.

What it is

Glutamate is the primary excitatory neurotransmitter in the central nervous system, used by an estimated 80% of synapses. It is essential for learning, memory, and virtually all cognitive function.

Glutamate and depression

Disruption of glutamate signaling — including in NMDA, AMPA, and metabotropic receptor systems — has been increasingly implicated in depression pathophysiology over the past two decades.

Therapeutic implications

Ketamine, esketamine, and several investigational antidepressants target glutamate signaling, marking a meaningful shift from the historical monoamine focus.

Educational only. Not medical advice. Discuss treatment decisions with a qualified clinician.

About the author

Founder and publisher of Ketalux, based in Chicago, Illinois. Ketalux.com is owned and operated by iDigits LLC. Ira commissions and edits the site's articles and believes ketamine therapy — used responsibly — offers real hope for people living with depression, anxiety, PTSD, and chronic pain. Contact: ira@idigits.com.

Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.